Prevalence and Characterisation of Asthma Patients According to Disease Severity in Portugal

Trial Identifier: D2287R00155
Sponsor: AstraZeneca
Collaborator:
Faculdade de Medicina da Universidade do Porto - CINTESIS
Universidade do Minho - ICVS
NCTID:: NCT05169619
Start Date: April 2021
Primary Completion Date: March 2024
Study Completion Date: March 2024
Condition: Asthma

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
Portugal Alpedorada, Portugal
Portugal Arazede, Portugal
Portugal Aveiro, Portugal
Portugal Braga, Portugal
Portugal Cascais, Portugal
Portugal Coimbra, Portugal
Portugal Evora, Portugal
Portugal Fafe, Portugal
Portugal Felgueiras, Portugal
Portugal Gilao de Tavira, Portugal
Portugal Horizonte -Matosinhos, Portugal
Portugal Lagoa - Matosinhos, Portugal
Portugal Leiria, Portugal
Portugal Lisboa - conchas, Portugal
Portugal Lisboa - Olivais, Portugal
Portugal Lisboa - Parque, Portugal
Portugal Mafra, Portugal
Portugal Massama, Portugal
Portugal Oceanos - Matosinhos, Portugal
Portugal Oeiras, Portugal
Portugal Ovar, Portugal
Portugal Pinhal Novo, Portugal
Portugal Ponte, Portugal
Portugal Porto, Portugal
Portugal Quinta do Conde, Portugal
Portugal Ria Formosa, Portugal
Portugal Ribeiro de Pena, Portugal
Portugal Rio de Mouro, Portugal
Portugal Tomar, Portugal
Portugal Tondela, Portugal
Portugal Torres Vedras, Portugal
Portugal Viana do Castelo, Portugal
Portugal Vila do Conde, Portugal
Portugal Vila Nova da Barquinha, Portugal
Portugal Vila Nova de Gaia, Portugal
Portugal Vila Real, Portugal
Portugal Vouzela, Portugal